新生儿发生产肺炎克雷伯碳青霉烯酶的肺炎克雷伯菌定植的危险因素分析

马明圣; 王丹华; 孙秀静; 李正红; 王晨

doi:10.7499/j.issn.1008-8830.2014.10.002

PDF(1123 KB)

HTML

中国当代儿科杂志 ›› 2014, Vol. 16 ›› Issue (10) : 970-974. DOI: 10.7499/j.issn.1008-8830.2014.10.002

世界肺炎日专题

新生儿发生产肺炎克雷伯碳青霉烯酶的肺炎克雷伯菌定植的危险因素分析

马明圣, 王丹华, 孙秀静, 李正红, 王晨

作者信息 +

Risk factors for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae colonization in neonates

MA Ming-Sheng, WANG Dan-Hua, SUN Xiu-Jing, LI Zheng-Hong, WANG Chen

Author information +

文章历史 +

摘要

目的探讨新生儿重症监护室（NICU）新生儿发生产肺炎克雷伯碳青霉烯酶的肺炎克雷伯菌（KPC-Kp）定植的危险因素。方法采用病例对照研究方法，病例组为NICU 住院新生儿中有KPC-Kp 定植的新生儿9 例，随机选取同期NICU 无该菌定植的新生儿18 例作为对照组。对两组行单因素及logistic 多因素回归分析了解定植KPC-Kp 的危险因素。结果单因素分析显示有统计学意义的因素有：出生胎龄、出生体重、住院天数、呼吸机使用时间、先天性心脏病、经外周静脉穿刺中心静脉插管、外科手术、静脉营养时间、使用碳青霉烯类抗生素及使用时间、使用糖肽类抗生素。Logistic 多因素回归分析显示碳青霉烯类抗生素使用时间（>4 d）是NICU 新生儿定植KPC-Kp 的独立危险因素（OR=18.7，95%CI：1.98~175.5，P=0.01）。控制该菌定植方法包括对定植KPC-Kp 新生儿的隔离、监测以及抗生素的合理使用。结论较长时间使用碳青霉烯类抗生素是NICU新生儿发生KPC-Kp 定植的独立危险因素。

Abstract

Objective To identify risk factors for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) colonization in neonates hospitalized in the neonatal intensive care unit (NICU). Methods A case-control study was conducted. The case group included nine patients colonized with KPC-Kp between 1 August 2012 and 31 April 2013 and the controls were selected randomly from patients without KPC-Kp colonization during the same period. Univariable analysis and multivariable logistic regression analysis were conducted to identify risk factors for KPC-Kp colonization. Results The univariable analysis showed 11 factors associated with KPC-Kp colonization:gestational age, birth weight, length of hospital stay, duration of mechanical ventilation, congenital heart disease,peripherally inserted central catheter, surgical operation, duration of intravenous nutrition, carbapenems use, duration of carbapenems use and glycopeptides use. The multivariable logistic regression analysis showed that exposure to more than 4 days of carbapenems use (OR=18.7, 95%CI: 1.98-175.5, P=0.01) was an independent risk factor for KPCKp colonization. The intervention to control KPC-Kp colonization included contact isolation, active surveillance, and rational use of antibiotics. Conclusions Exposure to prolonged use of carbapenems is an independent risk factor for the development of KPC-Kp colonization in neonates hospitalized in the NICU.

导出引用

马明圣, 王丹华, 孙秀静, 李正红, 王晨. 新生儿发生产肺炎克雷伯碳青霉烯酶的肺炎克雷伯菌定植的危险因素分析[J]. 中国当代儿科杂志. 2014, 16(10): 970-974 https://doi.org/10.7499/j.issn.1008-8830.2014.10.002

MA Ming-Sheng, WANG Dan-Hua, SUN Xiu-Jing, LI Zheng-Hong, WANG Chen. Risk factors for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae colonization in neonates[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(10): 970-974 https://doi.org/10.7499/j.issn.1008-8830.2014.10.002

参考文献

[1] 徐焱, 王丹华, 徐英春. 新生儿重症监护病房中部分定植细菌定植特点及变化规律[J]. 临床儿科杂志, 2008, 26(3): 209-212.
[2] 麦菁芸, 朱敏丽, 陈春, 等. 新生儿肺炎克雷伯菌败血症临床特点和药敏分析[J]. 中国当代儿科杂志, 2010, 12(9): 700-703.
[3] Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2001, 45(4): 1151-1161.
[4] Borer A, Saidel-Odes L, Eskira S, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumonia[J]. Am J Infect Control, 2012, 40(5): 421-425.
[5] Clinical and Laboratory Standards Institute (CLSI).M100-S20—Performance standards for antimicrobialsusceptibility testing[S]. 2010.
[6] Carvalhaes CG, Picâo RC, Nicoletti AG, et al. Cloverleaf test(modified Hodge test) for detecting carbapenemase productionin Klebsiella pneumoniae: be aware of false positive results[J]. JAntimicrob Chemother, 2010, 65(2): 249-251.
[7] Hidron AI, Edwards JR, Patel J, et al. NHSN annual update:antimicrobial-resistant pathogens associated with healthcareassociatedinfections: annual summary of data reported to theNational Healthcare Safety Network at the Centers for DiseaseControl and Prevention, 2006–2007[J]. Infect Control HospEpidemiol, 2008, 29(11): 996-1011.
[8] Nordmann P, Cuzon G, Naas T. The real threat of Klebsiellapneumonia carbapenemase-producing bacteria [J]. Lancet InfectDis, 2009, 9(4): 228-236.
[9] Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al.Predictors of carbapenem-resistant Klebsiella pneumoniaeacquisition among hospitalized adults and effect of acquisitionon mortality[J]. Antimicrob Agents Chemother, 2008, 52(3):1028-1033.
[10] Orsi GB, García-Fernández A, Giordano A, et al. Risk factorsand clinical significance of ertapenem-resistant Klebsiellapneumoniae in hospitalised patients[J]. J Hosp Infect, 2011,78(1): 54-58.
[11] Shilo S, Assous MV, Lachish T, et al. Risk factors for bacteriuriawith carbapenem-resistant Klebsiella pneumoniae and its impacton mortality: a case-control study[J]. Infection, 2013, 41(2):503-509.
[12] Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. KPCproducingKlebsiella pneumoniae enteric colonization acquiredduring intensive care unit stay: the significance of risk factorsfor its development and its impact on mortality[J]. DiagnMicrobiol Infect Dis, 2013, 77(2): 169-173.
[13] Kofteridis DP, Valachis A, Dimopoulou D, et al. Risk factorsfor carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study[J]. J Infect Chemother,2014, 20(5): 293-297.
[14] Munoz-Price LS, Quinn JP. The spread of Klebsiella pneumoniacarbapenemases: a tale of strains, plasmids, and transposons[J].Clin Infect Dis, 2009, 49(11): 1739-1741.
[15] Guh AY, Limbago BM, Kallen AJ. Epidemiology and preventionof carbapenem-resistant Enterobacteriaceae in the United States[J]. Expert Rev Anti Infect Ther, 2014, 12(5): 565-580.
[16] 徐英春, 肖永红, 卓超, 等. 中国碳青霉烯类耐药肠杆菌科细菌的流行病学和防控策略[J]. 中国执业药师, 2013, 10(4):3-8.
[17] Harris AD, Karchmer TB, Carmeli Y, et al. Methodologicalprinciples of caseecontrol studies that analyzed risk factors forantibiotic resistance: a systematic review [J]. Clin Infect Dis,2001, 32(7): 1055-1061.